Christina Lake Cannabis Corp. (the “Company” or “CLC” or
“Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:
CLB) is pleased to announce that it has completed an
eight-week controlled testing period for a Cosolvent Injection
System (“CIS”) add-on developed by Vitalis Extraction Technology,
Inc. (“Vitalis”) for its CO2 extraction machinery. This
installation of the Vitalis CIS is the first of its kind in the
cannabis industry. The Vitalis CIS add-on is designed to enhance
the extraction process for cannabis and hemp by using an
ethanol-powered mechanism to significantly reduce runtime and
operational costs as well as to improve winterization, both of
which are important considerations in the Company’s extraction
operations.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/c52c4d41-ee3a-46ec-ad87-bd2730d28767
Readers using news aggregation services
may be unable to view the media above. Please access SEDAR or the
Investor Relations section of the Company’s website for a version
of this press release containing all published media.
The baseline throughput rate and extraction times
of the Company’s Vitalis R-200 extraction machine is approximately
30 kg / 66.1 lb of biomass in a period of seven to eight hours.
Over the course of Q1 2021, the addition of the Vitalis CIS
resulted in approximately 90 kg / 198.4 lb of biomass being
processed in the same timeframe. Moreover, an analysis of extracts
completed using the Vitalis CIS showed an improvement in the
overall quality of the extract. Such results included greater than
90% efficacy with a crude extract consisting of less than 10% fats
and waxes; properties which reflect a favourable level of purity
requiring less refinement for a finished product.
More information about Vitalis’ CIS technology can be found on
its website:
https://vitaliset.com/marketing/co2-extraction-with-vitalis/
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a6447d74-765d-4113-bdc4-e9746fcc96fb
Readers using news aggregation services
may be unable to view the media above. Please access SEDAR or the
Investor Relations section of the Company’s website for a version
of this press release containing all published media.
Joel Dumaresq, CEO of Christina Lake Cannabis,
explained how the Company’s growth ambitions as an innovator in
cannabis production will be expedited with CLC’s recent purchase of
the new Vitalis CIS technology and its continued partnership with
Vitalis. “At the end of 2020, we found ourselves in a situation in
which we were limited to completing only three production runs on a
given day, which translates to approximately 90 kg / 198.4 lb of
biomass per day or 450 kg / 992 lb per week,” said Mr. Dumaresq.
“It became very apparent that there simply wouldn’t be enough hours
in the year to be able to effectively process the yield from our
2020 harvest season. Being approached by Vitalis as the first
customer to bring the new cosolvent injection system into our
operations was very timely as it enabled us to economically improve
our efficiency in producing cannabis extracts. We can now
consistently process upwards of 250 kg / 551 lb of biomass per day
or 1,250 kg / 2,755 lb per week with ease, and that’s a significant
improvement for the Company. It also supports the shift we are
making from our wholesale-only model to new downstream initiatives
that lends to expanding both our cultivation and production
capabilities.”
“Engineered as a plug-and-play add-on rather than an alteration
to CO2 extraction equipment, the Vitalis CIS design allows for
continued operation with the option to operate CO2 as a
mono-solvent if desired,” commented Vitalis co-founder and CEO,
Joel Sherlock. “By injecting a controlled amount of ethanol into
the CO2 extraction process, the cosolvent system leverages the
benefits of CO2 extraction (capturing terpenes, targeting desired
cannabinoids, lowering operating costs) and the power of ethanol.
Technical solutions for our customers to keep pace in the cannabis
industry of today means delivering on flexibility, reliability, and
most importantly... quality. What we’ve proven with the Vitalis CIS
is that optimized ethanol use at the discretion of our customers
does not need to come at the compromise of product quality or cost.
We’ve already seen incredible results at Christina Lake Cannabis
with preliminary extractions – a little over 20 L of ethanol per
extraction for each run and getting greater than 90% of
cannabinoids out of it. An ethanol-only system of equivalent size
would mean using more than 100 L of ethanol in one run, so you can
see the business rationale.”
Mr. Dumaresq added: “One thing CLC will never compromise on is
the consistency and quality of our products, and we are pleased to
say that the Vitalis CIS upholds that promise. Our efforts in
perfecting our process and protecting the purity of our plants this
year will mean driving resources into building out new genetics in
our seed bank, refining our strains, and delivering that bumper
crop that will keep our teams busy and continue to strengthen those
seed-to-shelf relationships we have with our customers.”
About Christina Lake Cannabis Corp.
Christina Lake Cannabis Corp. is a licensed producer of cannabis
under the Cannabis Act. It has secured a standard cultivation
licence and corresponding processing/sales amendment from Health
Canada (March 2020 and August 2020, respectively) as well as a
research and development licence (early 2020). CLC’s facility
consists of a 32-acre property, which includes over 950,000 square
feet of outdoor grow space, offices, propagation and drying rooms,
research facilities, and a facility dedicated to processing and
extraction. CLC also owns a 99-acre plot of land adjoining its
principal 32-acre site, which enables the Company to grow at a much
larger scale. CLC cultivates cannabis using strains specifically
developed for outdoor cultivation and in its inaugural harvest year
produced 32,500 kg (71,650 lb) on its existing facility before
developing an adjacent 99-acre expansion property. Such an
expansion will ultimately bring CLC’s annual cultivation footprint
to over 4.35 million square feet, which could enable at least
150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown
cannabis to be produced annually by the Company.
On behalf of Christina Lake Cannabis Corp.:
Joel DumaresqCEO and Director
For more information about CLC, please visit:
www.christinalakecannabis.com
Jamie FrawleyInvestor Relations and Media
Inquiriesjamie@clcannabis.com 416-268-9432
About VitalisVitalis Extraction Technology Inc.
(Vitalis) is a privately owned, Kelowna, BC–based engineering and
manufacturing company, producing industrial supercritical CO2
extraction solutions for the cannabis, hemp, pharmaceuticals,
F&B and essential oil industries. The company’s core focus on
innovation and design around reliability, scalability and
continuous operation has vaulted it to the forefront of the global
market. Visit vitaliset.com for more information.
Raushanna SalhiMarketing
ManagerRaush.salhi@vitaliset.com250-864-2985
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND
DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS
RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES
PROVIDER.
Forward-Looking Information: This news release includes certain
statements that may be deemed “forward-looking statements.” The use
of any of the words “anticipate,” “continue,” “estimate,” “expect,”
“may,” “will,” “would,” “project,” “should,” “believe” and similar
expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions
on which the forward-looking statements are based are reasonable,
undue reliance should not be placed on the forward-looking
statements because the Company can give no assurance that they will
prove to be correct. Since forward-looking statements address
future events and conditions, by their very nature they involve
inherent risks and uncertainties. These statements speak only as of
the date of this News Release. Actual results could differ
materially from those currently anticipated due to a number of
factors and risks including various risk factors discussed in the
Company’s disclosure documents which can be found under the
Company’s profile on http://www.sedar.com.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jul 2023 to Jul 2024